Molecular Biology and Immunology Discoveries Drive Novel Strategies for Lymphoma

Catherine M. Diefenbach, MD
Published: Sunday, Mar 22, 2015
NYU Cancer InstituteCatherine M. Diefenbach, MD
Catherine M.
Diefenbach, MD
Assistant Professor, Division of Hematology and Medical Oncology
Department of Medicine Member
Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical CenterDr. Catherine M. Diefenbach
Lymphomas are a heterogeneous and complex group of malignancies, with more than 67 distinct subtypes. The American Cancer Society estimates that lymphoma will account for nearly 72,000 new cases of cancer this year and, even more alarming, 20,000 deaths in 2015 alone. Fortunately, recent developments in research activity have unveiled new findings on the biology of lymphomas, and the complex relationship between the lymphoma cell and the cells that surround it. These biologic insights point to distinct mechanisms that will aid in better stratifying patients for individualized therapies, and provide increased options for patients with advanced disease, where treatments remain limited.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Publication Bottom Border
Border Publication